Genomic correlates of the response to first-line PD-1 blockade plus chemotherapy in patients with advanced non-small-cell lung cancer
These findings indicate that a 15-gene panel can serve as a negative prediction biomarker for first-line PD-1 blockade plus chemotherapy in patients with advanced NSCLC.
Authors
- Fengying Wu (ORCID: https://orcid.org/0000-0001-5129-0528)
- Henghui Zhang (ORCID: https://orcid.org/0000-0002-2820-7447)
- Shengxiang Ren (ORCID: https://orcid.org/0000-0001-8767-9850)
- Chunxia Su (ORCID: https://orcid.org/0000-0003-1632-9487)
- Caicun Zhou (ORCID: https://orcid.org/0000-0002-6958-0766)
- Ying Yang (ORCID: https://orcid.org/0000-0002-0026-7659)
- Huaibo Sun (ORCID: https://orcid.org/0009-0000-8943-7679)
- Jiao Zhang (ORCID: https://orcid.org/0000-0001-8218-3688)
- Haiping Zhang (ORCID: https://orcid.org/0009-0003-1501-3736)
- Jian Chen (ORCID: https://orcid.org/0009-0004-5036-7721)
- Tao Jiang (ORCID: https://orcid.org/0000-0002-9205-8183)
- Xiaoxia Chen (ORCID: https://orcid.org/0000-0002-2421-747X)
- Fei Zhou
- Haowei Wang (ORCID: https://orcid.org/0009-0004-1186-4303)
Institutions
- Tongji University (CN)
- Capital Medical University (CN)
- Shanghai Pulmonary Hospital (CN)
- Beijing Shijitan Hospital (CN)
- Genecast (China) (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1097/cm9.0000000000003094
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- Shanghai Rising-Star Program
- Shanghai Municipal Health and Family Planning Commission